Donor graft size, age and sex of patient affects ECD

Article

Increased donor graft size, younger donor age, and being female donor were linked to higher endothelial cell density (ECD) in patients who underwent penetrating keratoplasty for endothelial dysfunction conditions

Increased donor graft size, younger donor age, and being female donor were linked to higher endothelial cell density (ECD) in patients who underwent penetrating keratoplasty for endothelial dysfunction conditions, according to a study in the Archives of Ophthalmology.

Dr Jonathon H. Lass et al., Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio, USA, conducted an investigation on a collection of Cornea Donor Study participants. A central reading center was used to determine preoperative and postoperative endothelial cell densities (ECDs). To identify the baseline factors related to ECD multivariate regression analyses were performed.

The median endothelial cell loss after 5 years was found to be 68% for grafts measuring 8.0 to 9.0 mm, 75% for grafts 7.0 mm to 8.0 mm in diameter and 74% for grafts 8.0 mm in diameter. Female donors demonstrated a 67% cell loss compared to a 72% cell loss amongst male donors. Factors not significantly associated with long-term ECD changes included method of tissue retrieval, donor cause of death, history of diabetes, and time from death to preservation or to surgery.

It was concluded that a larger donor graft size and being a younger, female donor was linked to higher ECD. The findings suggest the possibility of similar links that could exist after endothelial keratoplasty.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.